Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase InhibitorsUltan McDermott, Jeffrey Settleman, A. John Iafrate et al.|Cancer Research|2008Cited by 403
Identification of genotype-correlated sensitivity to selective kinase inhibitors by using high-throughput tumor cell line profilingUltan McDermott, Jeffrey Settleman, Lori Dowell et al.|Proceedings of the National Academy of Sciences|2007Cited by 358
Ligand-Dependent Platelet-Derived Growth Factor Receptor (PDGFR)-α Activation Sensitizes Rare Lung Cancer and Sarcoma Cells to PDGFR Kinase InhibitorsUltan McDermott, Jeffrey Settleman, Rachel Y. Ames et al.|Cancer Research|2009Cited by 98
Analyses of circulating tumor cell (CTC) dynamics and treatment response in prostate cancer using the CTC-chip microfluidic deviceR.J. Lee, Daniel A. Haber, Shannon L. Stott et al.|Journal of Clinical Oncology|2009Cited by 1
Data from Genomic Alterations of Anaplastic Lymphoma Kinase May Sensitize Tumors to Anaplastic Lymphoma Kinase InhibitorsUltan McDermott, Jeffrey Settleman, A. John Iafrate et al.|Unknown|2023Cited by 0